Good MorningEquity markets started Tuesday's session on an uncertain footing after tensions in Ukraine escalated. However, the market quickly regained footing to confirm support at a critical level, aligning with the election-inspired rally two weeks ago. With this in play, the odds are high that the election-driven rally is not over and that the S&P 500 index will soon set a new high.
Results from Walmart aided the market rebound. The world's largest employer outpaced consensus on the top and bottom lines and raised its guidance, citing resilient consumer health and steady spending. The news suggests the holiday shopping season will be merry and bright, lifting Walmart's stock price by 5% to set a new all-time high. Analysts are lifting their targets for WMT stock, which may continue to trend higher through the end of the year. Featured: J.P. Morgan’s warns of "most predictable crisis in history" (Behind the Markets) |
Markets | |
Certain stocks in the market are not supposed to sell off at any time, and some brands and business models are widely known to be rock-solid and relatively immune to volatility. However, every once in a while, the system throws an unexpected event at these companies, rendering most volatility mode... Read the Full Story |
|
|
Stocks | | Most U.S. stocks are rising Thursday after more companies said they’re making fatter profits than expected. Market superstar Nvidia also topped forecasts, but Wall Street’s ambivalence about whether the heavyweight's report was impressive enough is keeping indexes in check. The S&P 500 was 0.2% ... Read the Full Story |
|
Markets | |
Palo Alto Network’s (NASDAQ: PANW) stock price has been in a multi-year uptrend that will continue for many more years because of its leadership position in cybersecurity. It is the world’s leading cybersecurity provider, and its business is supported by the increasing use of digitiz... Read the Full Story |
|
From Our PartnersJuan Villaverde called the top and bottom of every crypto bull market since 2012.
He believes Bitcoin will go to $150,000 — or more.
But there’s one coin he thinks could go even higher. | | This could be his favorite coin. |
|
Markets | |
Tepid guidance or not, the TJX Companies (NYSE: TJX) stock price can hit another new high this year because the retail trends driving it remain in place. Those include growth driven by price-conscious shoppers, outperformance, margin strength, cash flow, and capital returns, which are expected t... Read the Full Story |
|
Stocks | | One of Asia’s richest men, Indian tycoon Gautam Adani, is again in the spotlight. His companies’ stocks plunged up to 20% in value Thursday after he was indicted by U.S. prosecutors on charges that he duped investors in a massive solar energy project in India by concealing that it was being facilita... Read the Full Story |
|
|
Markets | |
Medtronic’s (NYSE: MDT) share price is down significantly from its peak in 2021, providing investors a deep-value opportunity. The stock price is down because of the post-COVID correction and headwinds leading to sluggish growth, which are factors that will not last forever. What will remain... Read the Full Story |
|
Markets | | Bitcoin topped $98,000 for the first time Thursday, extending a streak of record after record highs since the U.S. presidential election. The cryptocurrency has rocketed more than 40% in just two weeks. Now, bitcoin is at the doorstep of $100,000. Cryptocurrencies and a handful of related investment... Read the Full Story |
|
Markets | | Just a few weeks ago, the path ahead for the Federal Reserve looked straightforward: With inflation cooling and the job market slowing, the Fed appeared on track to steadily cut interest rates.In September, its officials predicted that they would reduce their benchmark rate four times next year, on ... Read the Full Story |
|
Markets | | Nvidia has once again turned out quarterly results that exceeded Wall Street's forecasts. The company has seen soaring demand for its semiconductors, which are used to power artificial intelligence applications. Revenue nearly doubled in the latest quarter from the same period a year earlier, Nvidia... Read the Full Story |
|
Markets | |
NVIDIA’s (NASDAQ: NVDA) growth is slowing, and margins are expected to compress, but so what? The company’s business has grown nearly 800% in the last four years and continues to grow. The Growth will eventually top out, but high levels of business are expected because of the AI revolu... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer and other proliferative diseases in the United States, the United Kingdom, and internationally. The company's lead product includes fadraciclib, a cyclin dependent kinase Inhibitors (CDK) that is in Phase 1/2 clinical trial for the treatment of solid tumors and hematological malignancies, as well as in combination with venetoclax to treat relapsed or refractory chronic lymphocytic leukemia; and Plogosertib, a polo-like kinase inhibitor program, which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors and hematological malignancies. It has a clinical collaboration agreement with the University of Texas MD Anderson Cancer Center to clinically evaluate the safety and efficacy of three cyclacel medicines in patients with hematological malignancies, including chronic lymphocytic leukemias, acute myeloid leukemias, myelodysplastic syndromes, and other advanced leukemias. The company was founded in 1996 and is headquartered in Berkeley Heights, New Jersey. | View Today's Stock Pick |
|